 | • レポートコード：QYR2104Z3154 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、不妊症サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生殖補助医療（ART）、不妊治療薬サービス、その他）、用途別市場規模（男性、女性）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・不妊症サービスの市場動向 ・企業の競争状況、市場シェア ・不妊症サービスの種類別市場規模（生殖補助医療（ART）、不妊治療薬サービス、その他） ・不妊症サービスの用途別市場規模（男性、女性） ・不妊症サービスの北米市場規模2016-2027（アメリカ、カナダ） ・不妊症サービスのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・不妊症サービスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・不妊症サービスの中南米市場規模2016-2027（メキシコ、ブラジル） ・不妊症サービスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（CARE facility、CooperSurgical、Ferring Pharmaceuticals、Monash IVF、Merck、Vitrolife、AbbVie、Apricus Biosciences、AstraZeneca、Auxogyn、Eli Lilly、EMD Serono、IKS International、InVitro Care、INVO Bioscience、Irvine Scientific、LifeGlobal、MedITEX、NMC Health、OB GYN Associates、OvaScience、Pantec Biosolutions、Reproductive Medicine Associates of New Jersey、The Sims Clinic、TriHealth、Virtus Health、Xytex Cryo International） ・結論 |
In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.
Some infertility Services include Assisted Reproductive Technology (ART), Infertility drug Services, Artificial Insemination and Fertility Surgeries.
Market Analysis and Insights: Global Infertility Services Market
The global Infertility Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infertility Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infertility Services market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infertility Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infertility Services market.
Global Infertility Services Scope and Market Size
Infertility Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infertility Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Assisted Reproductive Technology (ART)
Infertility Drug Services
Others
Segment by Application
Male
Female
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
CARE facility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife
AbbVie
Apricus Biosciences
AstraZeneca
Monash IVF
Merck
EMD Serono
IKS International
InVitro Care
INVO Bioscience
Irvine Scientific
LifeGlobal
MedITEX
NMC Health
OB GYN Associates
OvaScience
Pantec Biosolutions
Reproductive Medicine Associates of New Jersey
The Sims Clinic
TriHealth
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infertility Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Assisted Reproductive Technology (ART)
1.2.3 Infertility Drug Services
1.2.4 Others
1.3 Market by Application
1.3.1 Global Infertility Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Male
1.3.3 Female
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infertility Services Market Perspective (2016-2027)
2.2 Infertility Services Growth Trends by Regions
2.2.1 Infertility Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infertility Services Historic Market Share by Regions (2016-2021)
2.2.3 Infertility Services Forecasted Market Size by Regions (2022-2027)
2.3 Infertility Services Industry Dynamic
2.3.1 Infertility Services Market Trends
2.3.2 Infertility Services Market Drivers
2.3.3 Infertility Services Market Challenges
2.3.4 Infertility Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infertility Services Players by Revenue
3.1.1 Global Top Infertility Services Players by Revenue (2016-2021)
3.1.2 Global Infertility Services Revenue Market Share by Players (2016-2021)
3.2 Global Infertility Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infertility Services Revenue
3.4 Global Infertility Services Market Concentration Ratio
3.4.1 Global Infertility Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infertility Services Revenue in 2020
3.5 Infertility Services Key Players Head office and Area Served
3.6 Key Players Infertility Services Product Solution and Service
3.7 Date of Enter into Infertility Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infertility Services Breakdown Data by Type
4.1 Global Infertility Services Historic Market Size by Type (2016-2021)
4.2 Global Infertility Services Forecasted Market Size by Type (2022-2027)
5 Infertility Services Breakdown Data by Application
5.1 Global Infertility Services Historic Market Size by Application (2016-2021)
5.2 Global Infertility Services Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Infertility Services Market Size (2016-2027)
6.2 North America Infertility Services Market Size by Type
6.2.1 North America Infertility Services Market Size by Type (2016-2021)
6.2.2 North America Infertility Services Market Size by Type (2022-2027)
6.2.3 North America Infertility Services Market Size by Type (2016-2027)
6.3 North America Infertility Services Market Size by Application
6.3.1 North America Infertility Services Market Size by Application (2016-2021)
6.3.2 North America Infertility Services Market Size by Application (2022-2027)
6.3.3 North America Infertility Services Market Size by Application (2016-2027)
6.4 North America Infertility Services Market Size by Country
6.4.1 North America Infertility Services Market Size by Country (2016-2021)
6.4.2 North America Infertility Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Infertility Services Market Size (2016-2027)
7.2 Europe Infertility Services Market Size by Type
7.2.1 Europe Infertility Services Market Size by Type (2016-2021)
7.2.2 Europe Infertility Services Market Size by Type (2022-2027)
7.2.3 Europe Infertility Services Market Size by Type (2016-2027)
7.3 Europe Infertility Services Market Size by Application
7.3.1 Europe Infertility Services Market Size by Application (2016-2021)
7.3.2 Europe Infertility Services Market Size by Application (2022-2027)
7.3.3 Europe Infertility Services Market Size by Application (2016-2027)
7.4 Europe Infertility Services Market Size by Country
7.4.1 Europe Infertility Services Market Size by Country (2016-2021)
7.4.2 Europe Infertility Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Infertility Services Market Size (2016-2027)
8.2 Asia-Pacific Infertility Services Market Size by Type
8.2.1 Asia-Pacific Infertility Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infertility Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infertility Services Market Size by Type (2016-2027)
8.3 Asia-Pacific Infertility Services Market Size by Application
8.3.1 Asia-Pacific Infertility Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infertility Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infertility Services Market Size by Application (2016-2027)
8.4 Asia-Pacific Infertility Services Market Size by Region
8.4.1 Asia-Pacific Infertility Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infertility Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Infertility Services Market Size (2016-2027)
9.2 Latin America Infertility Services Market Size by Type
9.2.1 Latin America Infertility Services Market Size by Type (2016-2021)
9.2.2 Latin America Infertility Services Market Size by Type (2022-2027)
9.2.3 Latin America Infertility Services Market Size by Type (2016-2027)
9.3 Latin America Infertility Services Market Size by Application
9.3.1 Latin America Infertility Services Market Size by Application (2016-2021)
9.3.2 Latin America Infertility Services Market Size by Application (2022-2027)
9.3.3 Latin America Infertility Services Market Size by Application (2016-2027)
9.4 Latin America Infertility Services Market Size by Country
9.4.1 Latin America Infertility Services Market Size by Country (2016-2021)
9.4.2 Latin America Infertility Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infertility Services Market Size (2016-2027)
10.2 Middle East & Africa Infertility Services Market Size by Type
10.2.1 Middle East & Africa Infertility Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infertility Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infertility Services Market Size by Type (2016-2027)
10.3 Middle East & Africa Infertility Services Market Size by Application
10.3.1 Middle East & Africa Infertility Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infertility Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infertility Services Market Size by Application (2016-2027)
10.4 Middle East & Africa Infertility Services Market Size by Country
10.4.1 Middle East & Africa Infertility Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infertility Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 CARE facility
11.1.1 CARE facility Company Details
11.1.2 CARE facility Business Overview
11.1.3 CARE facility Infertility Services Introduction
11.1.4 CARE facility Revenue in Infertility Services Business (2016-2021)
11.1.5 CARE facility Recent Development
11.2 CooperSurgical
11.2.1 CooperSurgical Company Details
11.2.2 CooperSurgical Business Overview
11.2.3 CooperSurgical Infertility Services Introduction
11.2.4 CooperSurgical Revenue in Infertility Services Business (2016-2021)
11.2.5 CooperSurgical Recent Development
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Details
11.3.2 Ferring Pharmaceuticals Business Overview
11.3.3 Ferring Pharmaceuticals Infertility Services Introduction
11.3.4 Ferring Pharmaceuticals Revenue in Infertility Services Business (2016-2021)
11.3.5 Ferring Pharmaceuticals Recent Development
11.4 Monash IVF
11.4.1 Monash IVF Company Details
11.4.2 Monash IVF Business Overview
11.4.3 Monash IVF Infertility Services Introduction
11.4.4 Monash IVF Revenue in Infertility Services Business (2016-2021)
11.4.5 Monash IVF Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Infertility Services Introduction
11.5.4 Merck Revenue in Infertility Services Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Vitrolife
11.6.1 Vitrolife Company Details
11.6.2 Vitrolife Business Overview
11.6.3 Vitrolife Infertility Services Introduction
11.6.4 Vitrolife Revenue in Infertility Services Business (2016-2021)
11.6.5 Vitrolife Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Infertility Services Introduction
11.7.4 AbbVie Revenue in Infertility Services Business (2016-2021)
11.7.5 AbbVie Recent Development
11.8 Apricus Biosciences
11.8.1 Apricus Biosciences Company Details
11.8.2 Apricus Biosciences Business Overview
11.8.3 Apricus Biosciences Infertility Services Introduction
11.8.4 Apricus Biosciences Revenue in Infertility Services Business (2016-2021)
11.8.5 Apricus Biosciences Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Infertility Services Introduction
11.9.4 AstraZeneca Revenue in Infertility Services Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Auxogyn
11.10.1 Auxogyn Company Details
11.10.2 Auxogyn Business Overview
11.10.3 Auxogyn Infertility Services Introduction
11.10.4 Auxogyn Revenue in Infertility Services Business (2016-2021)
11.10.5 Auxogyn Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Infertility Services Introduction
11.11.4 Eli Lilly Revenue in Infertility Services Business (2016-2021)
11.11.5 Eli Lilly Recent Development
11.12 EMD Serono
11.12.1 EMD Serono Company Details
11.12.2 EMD Serono Business Overview
11.12.3 EMD Serono Infertility Services Introduction
11.12.4 EMD Serono Revenue in Infertility Services Business (2016-2021)
11.12.5 EMD Serono Recent Development
11.13 IKS International
11.13.1 IKS International Company Details
11.13.2 IKS International Business Overview
11.13.3 IKS International Infertility Services Introduction
11.13.4 IKS International Revenue in Infertility Services Business (2016-2021)
11.13.5 IKS International Recent Development
11.14 InVitro Care
11.14.1 InVitro Care Company Details
11.14.2 InVitro Care Business Overview
11.14.3 InVitro Care Infertility Services Introduction
11.14.4 InVitro Care Revenue in Infertility Services Business (2016-2021)
11.14.5 InVitro Care Recent Development
11.15 INVO Bioscience
11.15.1 INVO Bioscience Company Details
11.15.2 INVO Bioscience Business Overview
11.15.3 INVO Bioscience Infertility Services Introduction
11.15.4 INVO Bioscience Revenue in Infertility Services Business (2016-2021)
11.15.5 INVO Bioscience Recent Development
11.16 Irvine Scientific
11.16.1 Irvine Scientific Company Details
11.16.2 Irvine Scientific Business Overview
11.16.3 Irvine Scientific Infertility Services Introduction
11.16.4 Irvine Scientific Revenue in Infertility Services Business (2016-2021)
11.16.5 Irvine Scientific Recent Development
11.17 LifeGlobal
11.17.1 LifeGlobal Company Details
11.17.2 LifeGlobal Business Overview
11.17.3 LifeGlobal Infertility Services Introduction
11.17.4 LifeGlobal Revenue in Infertility Services Business (2016-2021)
11.17.5 LifeGlobal Recent Development
11.18 MedITEX
11.18.1 MedITEX Company Details
11.18.2 MedITEX Business Overview
11.18.3 MedITEX Infertility Services Introduction
11.18.4 MedITEX Revenue in Infertility Services Business (2016-2021)
11.18.5 MedITEX Recent Development
11.18 NMC Health
11.25.1 NMC Health Company Details
11.25.2 NMC Health Business Overview
11.25.3 NMC Health Infertility Services Introduction
11.25.4 NMC Health Revenue in Infertility Services Business (2016-2021)
11.25.5 NMC Health Recent Development
11.20 OB GYN Associates
11.20.1 OB GYN Associates Company Details
11.20.2 OB GYN Associates Business Overview
11.20.3 OB GYN Associates Infertility Services Introduction
11.20.4 OB GYN Associates Revenue in Infertility Services Business (2016-2021)
11.20.5 OB GYN Associates Recent Development
11.21 OvaScience
11.21.1 OvaScience Company Details
11.21.2 OvaScience Business Overview
11.21.3 OvaScience Infertility Services Introduction
11.21.4 OvaScience Revenue in Infertility Services Business (2016-2021)
11.21.5 OvaScience Recent Development
11.22 Pantec Biosolutions
11.22.1 Pantec Biosolutions Company Details
11.22.2 Pantec Biosolutions Business Overview
11.22.3 Pantec Biosolutions Infertility Services Introduction
11.22.4 Pantec Biosolutions Revenue in Infertility Services Business (2016-2021)
11.22.5 Pantec Biosolutions Recent Development
11.23 Reproductive Medicine Associates of New Jersey
11.23.1 Reproductive Medicine Associates of New Jersey Company Details
11.23.2 Reproductive Medicine Associates of New Jersey Business Overview
11.23.3 Reproductive Medicine Associates of New Jersey Infertility Services Introduction
11.23.4 Reproductive Medicine Associates of New Jersey Revenue in Infertility Services Business (2016-2021)
11.23.5 Reproductive Medicine Associates of New Jersey Recent Development
11.24 The Sims Clinic
11.24.1 The Sims Clinic Company Details
11.24.2 The Sims Clinic Business Overview
11.24.3 The Sims Clinic Infertility Services Introduction
11.24.4 The Sims Clinic Revenue in Infertility Services Business (2016-2021)
11.24.5 The Sims Clinic Recent Development
11.25 TriHealth
11.25.1 TriHealth Company Details
11.25.2 TriHealth Business Overview
11.25.3 TriHealth Infertility Services Introduction
11.25.4 TriHealth Revenue in Infertility Services Business (2016-2021)
11.25.5 TriHealth Recent Development
11.26 Virtus Health
11.26.1 Virtus Health Company Details
11.26.2 Virtus Health Business Overview
11.26.3 Virtus Health Infertility Services Introduction
11.26.4 Virtus Health Revenue in Infertility Services Business (2016-2021)
11.26.5 Virtus Health Recent Development
11.27 Xytex Cryo International
11.27.1 Xytex Cryo International Company Details
11.27.2 Xytex Cryo International Business Overview
11.27.3 Xytex Cryo International Infertility Services Introduction
11.27.4 Xytex Cryo International Revenue in Infertility Services Business (2016-2021)
11.27.5 Xytex Cryo International Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Infertility Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Assisted Reproductive Technology (ART)
Table 3. Key Players of Infertility Drug Services
Table 4. Key Players of Others
Table 5. Global Infertility Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Infertility Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Infertility Services Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Infertility Services Market Share by Regions (2016-2021)
Table 9. Global Infertility Services Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Infertility Services Market Share by Regions (2022-2027)
Table 11. Infertility Services Market Trends
Table 12. Infertility Services Market Drivers
Table 13. Infertility Services Market Challenges
Table 14. Infertility Services Market Restraints
Table 15. Global Infertility Services Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Infertility Services Market Share by Players (2016-2021)
Table 17. Global Top Infertility Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infertility Services as of 2020)
Table 18. Ranking of Global Top Infertility Services Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Infertility Services Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Infertility Services Product Solution and Service
Table 22. Date of Enter into Infertility Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Infertility Services Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Infertility Services Revenue Market Share by Type (2016-2021)
Table 26. Global Infertility Services Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Infertility Services Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Infertility Services Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Infertility Services Revenue Market Share by Application (2016-2021)
Table 30. Global Infertility Services Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Infertility Services Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Infertility Services Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Infertility Services Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Infertility Services Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Infertility Services Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Infertility Services Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Infertility Services Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Infertility Services Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Infertility Services Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Infertility Services Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Infertility Services Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Infertility Services Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Infertility Services Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Infertility Services Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Infertility Services Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Infertility Services Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Infertility Services Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Infertility Services Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Infertility Services Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Infertility Services Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Infertility Services Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Infertility Services Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Infertility Services Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Infertility Services Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Infertility Services Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Infertility Services Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Infertility Services Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Infertility Services Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Infertility Services Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Infertility Services Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Infertility Services Market Size by Country (2022-2027) & (US$ Million)
Table 62. CARE facility Company Details
Table 63. CARE facility Business Overview
Table 64. CARE facility Infertility Services Product
Table 65. CARE facility Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 66. CARE facility Recent Development
Table 67. CooperSurgical Company Details
Table 68. CooperSurgical Business Overview
Table 69. CooperSurgical Infertility Services Product
Table 70. CooperSurgical Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 71. CooperSurgical Recent Development
Table 72. Ferring Pharmaceuticals Company Details
Table 73. Ferring Pharmaceuticals Business Overview
Table 74. Ferring Pharmaceuticals Infertility Services Product
Table 75. Ferring Pharmaceuticals Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 76. Ferring Pharmaceuticals Recent Development
Table 77. Monash IVF Company Details
Table 78. Monash IVF Business Overview
Table 79. Monash IVF Infertility Services Product
Table 80. Monash IVF Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 81. Monash IVF Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Infertility Services Product
Table 85. Merck Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Vitrolife Company Details
Table 88. Vitrolife Business Overview
Table 89. Vitrolife Infertility Services Product
Table 90. Vitrolife Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 91. Vitrolife Recent Development
Table 92. AbbVie Company Details
Table 93. AbbVie Business Overview
Table 94. AbbVie Infertility Services Product
Table 95. AbbVie Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 96. AbbVie Recent Development
Table 97. Apricus Biosciences Company Details
Table 98. Apricus Biosciences Business Overview
Table 99. Apricus Biosciences Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 100. Apricus Biosciences Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Infertility Services Product
Table 104. AstraZeneca Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Auxogyn Company Details
Table 107. Auxogyn Business Overview
Table 108. Auxogyn Infertility Services Product
Table 109. Auxogyn Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 110. Auxogyn Recent Development
Table 111. Eli Lilly Company Details
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Infertility Services Product
Table 114. Eli Lilly Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 115. Eli Lilly Recent Development
Table 116. EMD Serono Company Details
Table 117. EMD Serono Business Overview
Table 118. EMD Serono Infertility Services Product
Table 119. EMD Serono Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 120. EMD Serono Recent Development
Table 121. IKS International Company Details
Table 122. IKS International Business Overview
Table 123. IKS International Infertility Services Product
Table 124. IKS International Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 125. IKS International Recent Development
Table 126. InVitro Care Company Details
Table 127. InVitro Care Business Overview
Table 128. InVitro Care Infertility Services Product
Table 129. InVitro Care Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 130. InVitro Care Recent Development
Table 131. INVO Bioscience Company Details
Table 132. INVO Bioscience Business Overview
Table 133. INVO Bioscience Infertility Services Product
Table 134. INVO Bioscience Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 135. INVO Bioscience Recent Development
Table 136. Irvine Scientific Company Details
Table 137. Irvine Scientific Business Overview
Table 138. Irvine Scientific Infertility Services Product
Table 139. Irvine Scientific Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 140. Irvine Scientific Recent Development
Table 141. LifeGlobal Company Details
Table 142. LifeGlobal Business Overview
Table 143. LifeGlobal Infertility Services Product
Table 144. LifeGlobal Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 145. LifeGlobal Recent Development
Table 146. MedITEX Company Details
Table 147. MedITEX Business Overview
Table 148. MedITEX Infertility Services Product
Table 149. MedITEX Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 150. MedITEX Recent Development
Table 151. NMC Health Company Details
Table 152. NMC Health Business Overview
Table 153. NMC Health Infertility Services Product
Table 154. NMC Health Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 155. NMC Health Recent Development
Table 156. OB GYN Associates Company Details
Table 157. OB GYN Associates Business Overview
Table 158. OB GYN Associates Infertility Services Product
Table 159. OB GYN Associates Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 160. OB GYN Associates Recent Development
Table 161. OvaScience Company Details
Table 162. OvaScience Business Overview
Table 163. OvaScience Infertility Services Product
Table 164. OvaScience Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 165. OvaScience Recent Development
Table 166. Pantec Biosolutions Company Details
Table 167. Pantec Biosolutions Business Overview
Table 168. Pantec Biosolutions Infertility Services Product
Table 169. Pantec Biosolutions Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 170. Pantec Biosolutions Recent Development
Table 171. Reproductive Medicine Associates of New Jersey Company Details
Table 172. Reproductive Medicine Associates of New Jersey Business Overview
Table 173. Reproductive Medicine Associates of New Jersey Infertility Services Product
Table 174. Reproductive Medicine Associates of New Jersey Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 175. Reproductive Medicine Associates of New Jersey Recent Development
Table 176. The Sims Clinic Company Details
Table 177. The Sims Clinic Business Overview
Table 178. The Sims Clinic Infertility ServicesProduct
Table 179. The Sims Clinic Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 180. The Sims Clinic Recent Development
Table 181. TriHealth Company Details
Table 182. TriHealth Business Overview
Table 183. TriHealth Infertility Services Product
Table 184. TriHealth Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 185. TriHealth Recent Development
Table 186. Virtus Health Company Details
Table 187. Virtus Health Business Overview
Table 188. Virtus Health Infertility Services Product
Table 189. Virtus Health Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 190. Virtus Health Recent Development
Table 191. Xytex Cryo International Company Details
Table 192. Xytex Cryo International Business Overview
Table 193. Xytex Cryo International Infertility Services Product
Table 194. Xytex Cryo International Revenue in Infertility Services Business (2016-2021) & (US$ Million)
Table 195. Xytex Cryo International Recent Development
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infertility Services Market Share by Type: 2020 VS 2027
Figure 2. Assisted Reproductive Technology (ART) Features
Figure 3. Infertility Drug Services Features
Figure 4. Others Features
Figure 5. Global Infertility Services Market Share by Application: 2020 VS 2027
Figure 6. Male Case Studies
Figure 7. Female Case Studies
Figure 8. Infertility Services Report Years Considered
Figure 9. Global Infertility Services Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Infertility Services Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Infertility Services Market Share by Regions: 2020 VS 2027
Figure 12. Global Infertility Services Market Share by Regions (2022-2027)
Figure 13. Global Infertility Services Market Share by Players in 2020
Figure 14. Global Top Infertility Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infertility Services as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Infertility Services Revenue in 2020
Figure 16. Global Infertility Services Revenue Market Share by Type (2016-2021)
Figure 17. Global Infertility Services Revenue Market Share by Type (2022-2027)
Figure 18. North America Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Infertility Services Market Share by Type (2016-2027)
Figure 20. North America Infertility Services Market Share by Application (2016-2027)
Figure 21. North America Infertility Services Market Share by Country (2016-2027)
Figure 22. United States Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Infertility Services Market Share by Type (2016-2027)
Figure 26. Europe Infertility Services Market Share by Application (2016-2027)
Figure 27. Europe Infertility Services Market Share by Country (2016-2027)
Figure 28. Germany Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Infertility Services Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Infertility Services Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Infertility Services Market Share by Region (2016-2027)
Figure 38. China Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Infertility Services Market Share by Type (2016-2027)
Figure 46. Latin America Infertility Services Market Share by Application (2016-2027)
Figure 47. Latin America Infertility Services Market Share by Country (2016-2027)
Figure 48. Mexico Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Infertility Services Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Infertility Services Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Infertility Services Market Share by Country (2016-2027)
Figure 54. Turkey Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Infertility Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. CARE facility Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 58. CooperSurgical Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 59. Ferring Pharmaceuticals Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 60. Monash IVF Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 62. Vitrolife Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 64. Apricus Biosciences Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 66. Auxogyn Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 68. EMD Serono Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 69. IKS International Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 70. InVitro Care Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 71. INVO Bioscience Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 72. Irvine Scientific Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 73. LifeGlobal Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 74. MedITEX Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 75. NMC Health Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 76. OB GYN Associates Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 77. OvaScience Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 78. Pantec Biosolutions Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 79. Reproductive Medicine Associates of New Jersey Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 80. The Sims Clinic Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 81. TriHealth Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 82. Virtus Health Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 83. Xytex Cryo International Revenue Growth Rate in Infertility Services Business (2016-2021)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
世界の男性不妊症市場規模・現状・予測（2021年-2027年） Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing …- 世界の男性不妊症市場規模・現状・予測（2021年-2027年） Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing …
- 世界の男性不妊治療市場規模・現状・予測（2021年-2027年） According to Word Health Organization, ‘Infertility is the inability of a sexually active, non-contraception couple to achieve pregnancy in one year’. About 15% of couples do not achieve pregnancy within 1year and seeking for infertility medical treatment. Less than 5% of world population is unwilli…
- 世界の男性不妊症診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Male Infertility Diagnosis and Treatment Market The global Male Infertility Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…
- 世界の不妊症治療薬市場規模・現状・予測（2021年-2027年） Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins. Market compet…